Immunotherapy has revolutionized modern cancer treatment.
The Immunotherapy Revolution
Checkpoint inhibitors have achieved long-term remissions (5+ years, functionally cured) in up to 22% of Stage IV melanoma patients. These results were unimaginable with chemotherapy just a decade ago.
How Checkpoints Work
Tumors exploit checkpoints (like PD-1/PD-L1) to disguise themselves. Checkpoint inhibitors (anti-PD-1 drugs) remove these brakes, unmasking the tumor to immune attack.
CAR-T Cell Therapy: Living Drugs
CAR-T therapy involves extracting a patient's own T-cells, genetically engineering them to target a specific cancer protein, and reinfusing them. It achieves 70-90% remission in some leukemias.
The Future of Cancer Immunotherapy
Cancer vaccines targeting neoantigens specific to each patient's tumor and oncolytic viruses represent the next wave of treatment breakthroughs.
Medical Disclaimer: The information on this website is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or other qualified health provider.